Pavmed
PAVmed Inc. is a medical device company based in New York, specializing in the development and commercialization of innovative medical technologies. Founded in 2014, PAVmed's product pipeline includes a diverse range of devices aimed at addressing various medical conditions. Key offerings include CarpX, a device for treating carpal tunnel syndrome; EsoCheck, a non-invasive tool for detecting esophageal cancer precursors; and PortIO, an implantable vascular access device. The company also develops DisappEAR, an antimicrobial ear tube, alongside other products like NextCath, a self-anchoring catheter, and Caldus, a disposable tissue ablation device. PAVmed aims to advance its technologies with efficiency and speed, leveraging the expertise of its founders, who are experienced medical device entrepreneurs and surgeons.
Top Regions
Top Stages
1 past transactions
Oncodisc
Acquisition in 2021
Oncodisc, Inc., based in Walnut Creek, California, is a medical technology company that specializes in manufacturing connected vascular access devices. These devices are embedded with advanced sensors and communication technology, designed to facilitate oncology drug delivery while monitoring the health of patients undergoing high-risk outpatient therapy. The company's product line includes an implantable vascular access port and data analytics solutions that provide status alerts for early signs of complications, enabling timely interventions and reducing hospitalizations. Additionally, Oncodisc offers a Remote Care Platform with mobile tools for patient-reported outcomes, telehealth services, and patient engagement. Incorporated in 2018, the company aims to enhance cancer care through integrated medical devices, remote monitoring, and data analytics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.